Canada closes dominance probe of pharma
Canada’s Competition Bureau has ended its investigation into Celgene, Pfizer and Sanofi-Aventis for allegedly denying generic drugmakers the medicine samples they need for regulatory testing to bring competing products to market.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10